CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 45 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $619,000 | -61.0% | 137,500 | -61.0% | 0.08% | -60.9% |
| Q1 2014 | $1,586,000 | -46.2% | 352,350 | -39.0% | 0.20% | -45.7% |
| Q4 2013 | $2,950,000 | +8.3% | 577,339 | -4.0% | 0.36% | +29.6% |
| Q3 2013 | $2,724,000 | -15.2% | 601,339 | -4.4% | 0.28% | -21.3% |
| Q2 2013 | $3,214,000 | – | 628,939 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
| BlackRock Inc. | 110,990 | $209,771 | 0.00% |
| Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |